Download PDF
Exp Clin Endocrinol Diabetes 1985; 85(2): 223-227
DOI: 10.1055/s-0029-1210440
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

In Vitro Effect of Ritodrinum on cAMP Concentration in Human Placentas of Different Gestational Age

B. Čemerikić, O. Genbačev, V. Šulović
  • Department of Endocrinology, Immunology and Nutrition, INEP (Director: Dr. M. Movsesijan), University of Belgrade, Zemun and Clinic of Gynaecology and Obstetrics, Faculty of Medicine (Director: Prof. Dr. V. Šulović), University of Belgrade, Belgrade/Yugoslavia
Further Information

Publication History

1984

Publication Date:
16 July 2009 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Beta-sympathomimetic drugs are clinically widely used in the management of threatened premature labour. The existence of beta-adrenergic receptors has been demonstrated in the human placenta and, as the stimulation of beta-adrenoreceptors is known to be mediated by cAMP, the purpose of this study was to compare the effect of Ritodrinum on cAMP concentration in placentas of different gestational age.

The in vitro treatment with Ritodrinum induced a five fold increase in cAMP concentration in 6—8 week old placenta, three fold increase in midgestation, but was without effect in term placenta. This result suggest that beta-mimetics in pharmacological concentrations could modulate trophoblast cell activity through the cAMP-dependent system during the first half of gestation

Key words

Human placenta - cAMP - ß-sympathomimetic drugs